Table 2

ED information by treatment group

ED informationRinger’s lactate (n=25)Normal saline (n=27)Total (n=52)
Arrival mode, n (%)
 Self15 (60.0)11 (40.7)26 (50.0)
 EMS10 (40.0)16 (59.3)26 (50.0)
CTAS, n (%)
 13 (12.0)0 (0.0)3 (5.8)
 213 (52.0)21 (77.8)34 (65.4)
 39 (36.0)6 (22.2)15 (28.8)
Vital signs (mean±SD)
 Systolic BP (mm Hg)130.9±24.4140.8±27.7136.0±26.4
 Diastolic BP (mm Hg)74.7±18.980.5±15.777.7±17.4
 HR (beats/min)112.8±26.8106.6±22.9109.6±24.8
 RR (breaths/min)19.9±5.720.5±5.020.2±5.3
 Temperature (°C)36.4±0.936.8±0.736.6±0.9
 O2 saturation (%)97.1±2.197.2±2.797.1±2.4
On O2 supplement at arrival, n (%)3 (12.0)3 (11.1)6 (11.5)
Blood glucose readings (mean±SD)
 Most recent home glucose (mmol/L)26.2±16.025.0±8.025.6±12.0
 EMS glucose, if arrival by EMS (mmol/L)27.2±8.322.5±7.524.1±7.7
 Initial point-of-care glucose (mmol/L)23.1±6.322.8±7.222.9±6.7
Likely precipitants of DKA, n (%)
 Poor glycaemic control10 (40.0)12 (44.4)22 (42.3)
 Non-adherence to prescribed medication regimen6 (24.0)8 (29.6)14 (26.9)
 Unknown cause6 (24.0)8 (29.6)14 (26.9)
 New diagnosis4 (16.0)1 (3.7)5 (9.6)
 Alcohol related2 (8.0)3 (11.1)5 (9.6)
 Infection induced4 (16.0)0 (0.0)4 (7.7)
Co-diagnoses to DKA, n (%)
 Pneumonia5 (20.0)0 (0.0)5 (9.6)
 Urinary tract infection2 (8.0)0 (0.0)2 (3.8)
 COVID-191 (4.0)0 (0.0)1 (1.9)
 Sarcoidosis1 (4.0)0 (0.0)1 (1.9)
 Bowel perforation1 (4.0)0 (0.0)1 (1.9)
 Supraventricular tachycardia1 (4.0)0 (0.0)1 (1.9)
 Bacteraemia0 (0.0)1 (3.7)1 (1.9)
  • SD (not included if n≤1).

  • CTAS, Canadian Triage and Acuity Scale; DKA, diabetic ketoacidosis; EMS, emergency medical services.